– USA, MD – BIOQUAL, Inc. (OTC: BIOQ) announced the appointment of Amy Johnston to its Board of Directors effective on December 31, 2024, replacing Charles Francisco who retired from the Board on that date.
About Amy Johnston
Amy Johnston has been working with and managing companies in the healthcare and biotech industries for over thirty years.
Amy Johnston holds a Bachelor of Arts in Government and English (dual degree) and a Master of Arts degree in Secondary English Education from the College of William and Mary in Virginia.
Among her career accomplishments:
- Led cross-functional teams to build commercial biotech teams and strategies while ensuring compliance with FDA regulations.
- Provided critical support in pre-launch and post-launch efforts for a Hepatitis C compound, achieving $1B in sales in the first year on the commercial market.
- Collaborated with media and advertising agencies, managed market teams, Key Opinion Leaders, and patient advocacy groups to educate both the medical community and the patients.
- Revised the strategy and operating model of a design/build employee-owned utility company, increasing revenue from $10 million to $25 million during the pandemic. Successfully valued and negotiated the sale of her interest in the company in 2022.
For more: https://bioqual.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.